The Scientist

» immunotherapy and neuroscience

Most Recent

image: Infographic: Targeting Cancer Antigens

Infographic: Targeting Cancer Antigens

By | April 1, 2017

Neoantigens may serve as valuable targets for new immunotherapies.

0 Comments

image: Targeting Tregs Halts Cancer’s Immune Helpers

Targeting Tregs Halts Cancer’s Immune Helpers

By | April 1, 2017

New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.

0 Comments

image: Paralyzed Man Moves Arm with Neuroprosthetic

Paralyzed Man Moves Arm with Neuroprosthetic

By | March 30, 2017

Two chips implanted in a quadriplegic patient’s motor cortex and 36 electrodes in his right arm allow the man to control the movement of his right arm and hand.

0 Comments

The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s. 

1 Comment

image: Consilience, Episode 2: In Tune

Consilience, Episode 2: In Tune

By | March 21, 2017

Ben Henry delves into the still-unanswered questions of where our musical preferences come from and what makes synesthetes tick.

0 Comments

image: Oxford University to Study Marijuana

Oxford University to Study Marijuana

By | March 20, 2017

Academics partner with a biotech firm to investigate cannabinoids and develop potential therapeutics.

0 Comments

image: Singing Through Tone Deafness

Singing Through Tone Deafness

By | March 17, 2017

Author Tim Falconer didn't take his congenital amusia lying down. With the help of neuroscientists and vocal coaches, he tried to teach himself to sing against all odds.

0 Comments

image: Tasmanian Devil Cancer Immunotherapy

Tasmanian Devil Cancer Immunotherapy

By | March 13, 2017

Researchers in Australia claim to have successfully used immunotherapy to treat devil facial tumor disease.

0 Comments

image: Cortical Interneurons Show Layer-Specific Activities

Cortical Interneurons Show Layer-Specific Activities

By | March 2, 2017

Researchers examine the firing patterns of interneurons throughout all layers of the somatosensory cortices of alert mice.  

0 Comments

image: Kite’s CAR T-Cell Therapy Success

Kite’s CAR T-Cell Therapy Success

By | March 1, 2017

More than one-third of lymphoma patients in a Phase 2 trial were clear of disease at six months, and no new safety concerns arose since the company’s three-month follow up.

0 Comments

Popular Now

  1. So You’ve Been Mistaken as a White Nationalist
  2. More Than 300,000 Atlantic Salmon Spill into Pacific
  3. Trump Releases Science Spending Priorities for FY2019
  4. How Journals Treat Papers from Researchers Who Committed Misconduct
AAAS